semaglutide + tirzepatide Semaglutide, recommended as first-line treatment of obesity and most of its complications in new guidance Semaglutide vs. Tirzepatide: What's the

Recommendation : Require prior authorization based on: Confirmed diagnosis of type 2 diabetes or BMI 30 (or 27 with comorbidities) Failure of first line therapy (i.e

Whether that translates into sustained, equitable treatment uptake will depend on factors the science alone cannot resolve: cost, coverage, access, and clinical support.

An important consideration for users with lactose sensitivity or those who've experienced bloating with other proteins

Instead, what you should be doing is a clinical assessment, a decision on starting dose, a short gap in injections, and then beginning Mounjaro at the appropriate starting point

Li J, Fan H, Liu W, Zhang J, Xiao Y, Peng Y, et al